News of positive data from Moderna’s (Cambridge, MA) Phase I trial of a COVID-19 vaccine has dominated this week’s headlines. Their vaccine is an mRNA-based vaccine—an entirely new approach to not only vaccines but also to therapeutics. mRNA-based drugs...
Last week, the FDA granted emergency-use approval for Sherlock Bioscience’s (Cambridge, MA) new coronavirus diagnostic. The test uses CRISPR genome editing to detect the presence of Sars-Cov-2, the virus that causes COVID-19. With the ability to return results...
Last week, we began our two-part series on COVID-19 antiviral drugs by reviewing the stages of the Sars-Cov-2 (the virus that causes COVID-19) lifecycle that might be prone to attack by these drugs, and explained how hydroxychloroquine (HCQ) works and discussed the...
For the past several weeks, we’ve been focusing on explaining the science behind vaccines, explaining the different types of vaccines that are in development to prevent Covid-19, the disease caused by the novel coronavirus Sars-Cov-2. This week, guest author Kevin...
Last week, we overviewed vaccine development and manufacture, focusing on those that use whole pathogens to protect us from a disease. This week, we examine subunit, polysaccharide, and DNA/RNA-based vaccines, which use different strategies to fight infection. We also...
As the COVID-19 pandemic continues to spread, governments, citizens, and healthcare workers everywhere turn their hopes to a new vaccine that will stop transmission. This WEEKLY takes a look at different types of vaccines and their manufacture, as well as what kind of...
From startups to the Fortune 500, we train employees at companies of all sizes. We offer customized, in-house courses and open enrollment classes. Visit Biotech Primer for more information.